A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Subjective Response to Treatment With Ramelteon in Adult Subjects With Chronic Insomnia by Utilizing an Interactive Voice Response System (IVRS) for Collecting Diary Data.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Takeda
- 23 Jan 2009 Official Title amended as reported by ClinicalTrials.gov.
- 28 May 2008 New trial record.